[Hyperhomocysteinemia: a new marker of vascular risk: affected vascular areas, its role in the pathogenesis of arteriosclerosis and thrombosis and treatment].
Córdoba Porras
A
A
Servicio de Bioquímica e Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona.
Blanco Vaca
F
F
González Sastre
F
F
D000328:Adult; D003324:Coronary Artery Disease / Q000097:blood* / Q000628:therapy; D003328:Coronary Thrombosis / Q000097:blood; D005260:Female; D006710:Homocysteine / Q000097:blood* / Q000378:metabolism; D006712:Homocystinuria / Q000097:blood / Q000188:drug therapy; D006801:Humans; D008297:Male; D008715:Methionine / Q000097:blood; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000097:blood; D011247:Pregnancy; D013924:Thrombophlebitis / Q000097:blood* / Q000628:therapy; D014815:Vitamins / Q000627:therapeutic use
D014815:Vitamins; D006710:Homocysteine; D008715:Methionine
Hiperhomocisteinemia, un nuevo marcador de riesgo vascular: territorios vasculares afectados, papel en la patogénesis de la arteriosclerosis y la trombosis y tratamiento.